Physician profile
Safa Tahmasebi
NPI 1649818048
$33,464.49
in general payments reported to CMS, 2019-2025
4 companies · $7,332 in 2025
The $7,332 reported for 2025 was more than what 94% of Prosthodontics providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.03 · 2020: $38.80 · 2021: $867 · 2022: $6,800 · 2023: $618 · 2024: $18K · 2025: $7,332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $20K · Consulting Fee: $4,201 · Food and Beverage: $1,904 · Gift: $46.03 · Entertainment: $28.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $19,500.00 |
| Consulting Fee | $4,200.60 |
| Food and Beverage | $1,903.98 |
| Gift | $46.03 |
| Entertainment | $28.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $18,937.28 | 2022-2025 | |
| Southern Implants North America INC | $12,999.01 | 2019-2025 | Inverta |
| Keystone Dental INC. | $1,107.63 | 2022-2023 | |
| Biohorizons Implant Systems INC. | $420.57 | 2024-2025 | Biohorizons, Biohorizons Dental Implants |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Safa Tahmasebi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.